WilliamHamptonBradleyMD
Obstetrics & Gynecology • Milwaukee, WIGynecologic Oncology
Assistant Professor, Obstetrics & Gynecology, Medical College of Wisconsin
Dr. Bradley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226Phone+1 414-805-6606Fax+1 414-805-2233- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Gynecologic Oncology, 2005 - 2008
University of MinnesotaResidency, Obstetrics and Gynecology, 2000 - 2004- University of Minnesota Medical SchoolClass of 2000
Certifications & Licensure
WI State Medical License 2008 - 2025
NY State Medical License 2005 - 2008
MN State Medical License 2002 - 2006- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA ...Mutch, D., Voulgari, A., Chen, X., Oaknin, A., Perez Fidalgo, J., Montosa, F., Herraez, A., Powell, M., Nowicka, M., Schaefer, G., Merchant, M., Yan, Y., Bradley, W., ...> ;Cancer. 2024 Jan 30
- Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer.Simpson, P., Zhang, L., Christian, Q., Uyar, D., Michener, C., Bishop, E., Hopp, E., Rader, J., Rose, P., Mahdi, H., Debernardo, R., Bradley, W.> ;Frontiers in Oncology. 2024 Jan 1
- Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies.Lindsey A McAlarnen, Christina Small, Lauren Tostrud, Amy Y Pan, Beth Erickson, Meena Bedi, William H Bradley> ;Brachytherapy. 2023 Jun 30
- Join now to see all
Press Mentions
Different Outcomes for Oshkosh Sisters in Cancer Drug TrialApril 30th, 2021
Professional Memberships
- Fellow
Hospital Affiliations
Froedtert and the Medical College of Wisconsin Froedtert HospitalMilwaukee, Wisconsin- Froedtert West Bend HospitalWest Bend, Wisconsin
- ThedaCare Medical Center-ShawanoShawano, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
